40 Results for "

NS3/4a

" in MedChemExpress (MCE) Product Catalog:
Products (40)

40 Results for "NS3/4a" in MCE Product Catalog:

46
46 Publications Verification
Cat. No.: HY-10241
CAS No.: 923604-59-5
Purity:  98.79%
Synonyms: TMC435; TMC435350
Research Areas:  

Infection

Simeprevir (TMC435; TMC435350) is an oral, potent and highly specific hepatitis C virus (HCV) NS3/4A protease inhibitor with a Ki of 0.36 nM. Simeprevir inhibits HCV replication with an EC50 of 7.8 nM. Simeprevir also potently suppresses SARS-CoV-2 replication and synergizes with Remdesivir. Simeprevir inhibits the main protease (M pro) and the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2, and also modulates host immune responses [4].
loading...
    loading...
44
44 Cited Publications
Cat. No.: HY-10235
CAS No.: 402957-28-2
Purity:  99.54%
Synonyms: VX-950
Target:  

HCV Protease HCV SARS-CoV

Research Areas:  

Infection

Telaprevir (VX-950) is a highly selective, reversible, and potent peptidomimetic inhibitor of the HCV NS3-4A protease, the steady-state inhibitory constant (Ki) of Telaprevir is 7 nM against a genotype 1 (H strain) NS3 protease domain plus a NS4A cofactor peptide [3]. Telaprevir inhibits SARS-CoV-2 3CL pro activity [4].
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-15298
CAS No.: 1350514-68-9
Purity:  99.99%
Synonyms: MK-5172
Target:  

HCV Protease HCV SARS-CoV

Research Areas:  

Infection

Grazoprevir (MK-5172) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Kis of 0.01 nM (gt1b), 0.01 nM (gt1a), 0.08 nM (gt2a), 0.15 nM (gt2b), 0.90 nM (gt3a), respectively . Grazoprevir inhibits SARS-CoV-2 3CL pro activity [3].
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-15298A
CAS No.: 1206524-86-8
Purity:  99.63%
Synonyms: MK-5172 potassium salt
Target:  

HCV HCV Protease SARS-CoV

Research Areas:  

Infection

Grazoprevir potassium salt (MK-5172 potassium salt) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Kis of 0.01 nM (gt1b), 0.01 nM (gt1a), 0.08 nM (gt2a), 0.15 nM (gt2b), 0.90 nM (gt3a), respectively . Grazoprevir potassium salt inhibits SARS-CoV-2 3CL pro activity [3].
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-15298B
CAS No.: 1350462-55-3
Purity:  99.99%
Synonyms: MK-5172 hydrate
Target:  

HCV HCV Protease SARS-CoV

Research Areas:  

Infection

Grazoprevir hydrate (MK-5172 hydrate) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Kis of 0.01 nM (gt1b), 0.01 nM (gt1a), 0.08 nM (gt2a), 0.15 nM (gt2b), 0.90 nM (gt3a), respectively . Grazoprevir hydrate inhibits SARS-CoV-2 3CL pro activity [3].
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-10238
CAS No.: 850876-88-9
Purity:  99.67%
Synonyms: ITMN-191; R7227; RO5190591; RG7227
Target:  

HCV Protease HCV SARS-CoV

Research Areas:  

Infection

Danoprevir (ITMN-191) is an orally active NS3/4A protease inhibitor for hepatitis C virus (HCV) with an IC50 of 0.29 nM and is selective for NS3/4A over a panel of 53 proteases (IC50 higher than 10 μM). Danoprevir (ITMN-191) inhibits HCV genotypes 1a, 1b, 4, 5, and 6 (IC50s=0.2-0.4 nM) as well as 2b and 3a (IC50s=1.6, 3.5 nM) . Danoprevir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 0.05 μM [3].
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-12594
CAS No.: 1216941-48-8
Purity:  99.87%
Synonyms: ABT-450; Veruprevir
Target:  

HCV Protease HCV SARS-CoV

Research Areas:  

Infection

Paritaprevir (ABT-450) is a potent, orally active and antiviral non-structural protein 3/4A (NS3/4A) protease inhibitor with EC50s of 1 and 0.21 nM against HCV 1a and 1b, respectively. Paritaprevir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 1.31 μM. Paritaprevir is metabolized primarily by cytochrome P450 (CYP) 3A. The plasma concentration and half-life of Paritaprevir can be enhanced by Ritonavir (a CYP450 inhibitor) [3] [4].
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-17634
CAS No.: 1365970-03-1
Synonyms: ABT-493
Target:  

HCV HCV Protease SARS-CoV

Research Areas:  

Infection

Glecaprevir is a novel HCV NS3/4A protease inhibitor, with IC50 values ranging from 3.5 to 11.3 nM. Glecaprevir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 4.09 μM .
loading...
    loading...
Cat. No.: HY-19840
CAS No.: 1535212-07-7
Synonyms: GS-9857
Target:  

HCV Protease

Research Areas:  

Infection Cancer

Voxilaprevir (GS-9857) is a noncovalent, reversible inhibitor of HCV NS3/4A protease inhibitor (PI) with pangenotypic antiviral activity . Voxilaprevir inhibits genotype 1b and 3a wild-type NS3 proteases with Ki values of 0.038 nM and 0.066 nM, respectively . Voxilaprevir is an orally active direct-acting antiviral agent (DAA) and can be used for HCV infection research .
loading...
    loading...
Cat. No.: HY-N12586
CAS No.: 603-17-8
Pheophytin a is a multi-target inhibitor, anticancer agent, antioxidant and antiviral agent. Pheophytin a directly binds to and inhibits HCV-NS3/4A protease (IC50=0.89 μM) to block viral replication. Pheophytin a also scavenges free radicals, reduces ferric ions, and exhibits cytotoxic activity against breast cancer cells. Pheophytin a effectively inhibits LPS-induced production of nitric oxide, prostaglandin E2, NOS2 and COX-2, as well as various pro-inflammatory cytokines, by downregulating the transcription levels of inflammatory mediators and blocking the ERK1/2 and STAT-1 pathways. In a low nerve growth factor environment, Pheophytin a also enhances ERK1/2 phosphorylation and synergistically promotes neurite outgrowth through MAPK pathway. Pheophytin a can be used to investigate the pathogenic mechanisms of diseases including chronic hepatitis C, sepsis, breast cancer and Alzheimer's disease [3] [4] .
loading...
    loading...
Cat. No.: HY-18563
CAS No.: 107622-80-0
Target:  

HCV

Research Areas:  

Infection

4-Phenoxybenzylamine inhibits the function of the NS3 protein by stabilizing an inactive conformation with an IC50 of about 500 μM against FL NS3/4a.
loading...
    loading...
Cat. No.: HY-15256
CAS No.: 801283-95-4
Purity:  98.58%
Synonyms: BI 201335
Target:  

HCV Protease

Research Areas:  

Infection

Faldaprevir (BI 201335) is a potent, orally active and selective noncovalent inhibitor of NS3/4A protease of HCV (hepatitis C virus) genotypes 1a and 1b, with Ki values of 2.6 and 2.0 nM, respectively. Faldaprevir inhibits HCV RNA replication, with EC50 values of 6.5 and 3.1 nM, respectively. Faldaprevir has potent antiviral activity against chronic HCV infection .
loading...
    loading...
Cat. No.: HY-10243
CAS No.: 923590-37-8
Synonyms: MK-7009
Target:  

HCV HCV Protease

Research Areas:  

Infection

Vaniprevir (MK-7009) is a non-covalent competitive inhibitor of the hepatitis C virus (HCV) NS3/4A protease.
loading...
    loading...
Cat. No.: HY-109571
CAS No.: 1009734-33-1
Purity:  98.16%
HZ-1157 inhibits HCV NS3/4A protease with an IC50 of 1.0 μmol/L. HZ-1157 (4a) has a high dengue virus inhibitory activity (EC50 = 0.15 μM) and is a relatively nontoxic (CC50 > 10 μM) dengue antiviral agent .
loading...
    loading...
Cat. No.: HY-14404
CAS No.: 924270-31-5
Target:  

HBV HCV Protease

Research Areas:  

Infection

MK-1220 is a covalently reversible inhibitor of the hepatitis C virus (HCV) NS3/4A protease (NS3/4A protease) with a Ki of 0.02 nM. MK-1220 in cell models simulating viral replication exhibits EC50s of 4 (with 10% fetal bovine serum) and 11 nM (50% normal human serum). MK-1220 can be used for the study of chronic hepatitis C virus infection .
loading...
    loading...
Cat. No.: HY-131905S
CAS No.: 1606150-08-6
BMS-986144 is an orally active inhibitor of HCV NS3/4A protease. BMS-986144 binds to the active site of HCV NS3/4A protease and induces conformational changes in the protease. BMS-986144 reduces time-dependent CYP3A4 inhibition, exhibits hepatic microsomal metabolic stability, and undergoes oxidation of the macrocyclic linker chain. BMS-986144 can be used in studies related to hepatitis C virus infection .
loading...
    loading...
Cat. No.: HY-19557
CAS No.: 1251165-81-7
Research Areas:  

Infection

IDX-320 is a Pipecolic acid (HY-Y0669) derivative. IDX-320 inhibits NS3/4a proteases across genotypes 1a, 1b, 2a, and 4a with an IC50 0.8-1.9 nM. IDX-320 can be used in the research of HCV infection .
loading...
    loading...
Cat. No.: HY-10235S
Synonyms: VX-950-d4
Telaprevir-d4 is the deuterium labeled Telaprevir. Telaprevir (VX-950) is a highly selective, reversible, and potent peptidomimetic inhibitor of the HCV NS3-4A protease, the steady-state inhibitory constant (Ki) of Telaprevir is 7 nM against a genotype 1 (H strain) NS3 protease domain plus a NS4A cofactor peptide [3]. Telaprevir inhibits SARS-CoV-2 3CLpro activity [4].
loading...
    loading...
Cat. No.: HY-17634R
CAS No.: 1365970-03-1
Synonyms: ABT-493 (Standard)
Research Areas:  

Infection

Glecaprevir (Standard) is the analytical standard of Glecaprevir. This product is intended for research and analytical applications. Glecaprevir is a novel HCV NS3/4A protease inhibitor, with IC50 values ranging from 3.5 to 11.3 nM. Glecaprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 4.09 μM .
loading...
    loading...
Cat. No.: HY-16773
CAS No.: 1098189-15-1
Synonyms: GS-9451
Research Areas:  

Infection

Vedroprevir (GS-9451) is an inhibitor for HCV NS3/4A protease with an IC50 of 3.2 nM. Vedroprevir is also an inhibitor for breast cancer resistant protein (BCRP) with an IC50 of 1.4 μM. Vedroprevir inhibits P-gp, MRP1 and MRP2 with IC50 of 34, 14.9 and 12 μM, respectively. Vedroprevir exhibits good pharmacokinetic characteristics in rats and dogs .
loading...
    loading...